Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
A concise primer comparing decentralization aspects of PoW and PoS, outlining key tradeoffs that impact security and resilience.
27,693 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Japan's quarterly sale of US Treasuries jolts bond markets, amplifying yield moves that could shape Bitcoin and other...
A couple with $4.2 million in retirement assets faces a $200,000 request from their 32-year-old daughter to fund a do...
Intel stock climbs about 5% after word that the company is in talks to acquire AI accelerator startup Tenstorrent, re...
Analysts say a confluence of demand, supply limits, and refinery maintenance could push U.S. gas prices higher throug...
Investors are weighing whether AMD can reach $600 this year as AI-driven demand and enterprise partnerships could lif...
SEA’s December 2025 payout fell 60% from 2024, exposing how its dividend is tied to cyclical freight profits rather t...
As market yields shift, a growing cohort of investors turning $400,000 into passive income is using Delaware Statutor...
Stocks climbed as heavyweight tech names posted solid results and ceasefire hopes supported risk appetite, sending th...
A retiree watched a $1.2m portfolio fall $187,000 in three weeks amid volatile markets. Experts say a bond sleeve cou...
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Truist’s head of originations is pushing a curiosity-driven, AI-enabled approach to mortgage lending as rates and dem...